Malignant hypertonic hyperpyrexia syndrome.
D000769:Anesthesia, Inhalation / Q000009:adverse effects*; D002648:Child; D003490:Cyanosis; D005260:Female; D005334:Fever; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007036:Hypothermia, Induced; D008297:Male; D009120:Muscle Cramp / Q000139:chemically induced; D009222:Myotonia / Q000139:chemically induced* / Q000628:therapy; D009609:Nitrous Oxide / Q000009:adverse effects; D013390:Succinylcholine / Q000009:adverse effects*
D013390:Succinylcholine; D009609:Nitrous Oxide; D006221:Halothane